{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T09:16:33Z","timestamp":1707902193343},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ejso.2006.11.030","type":"journal-article","created":{"date-parts":[[2007,1,6]],"date-time":"2007-01-06T12:11:19Z","timestamp":1168085479000},"page":"843-848","source":"Crossref","is-referenced-by-count":6,"title":["Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma"],"prefix":"10.1016","volume":"33","author":[{"given":"D.H.","family":"Koo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Yook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.T.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.K.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2006.11.030_bib1","first-page":"879","article-title":"Meta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal","volume":"12","author":"Hermans","year":"1994","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2006.11.030_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0959-8049(99)00076-3","article-title":"Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials","volume":"35","author":"Earle","year":"1999","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2006.11.030_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/11024150201680005","article-title":"Chemotherapy in gastric cancer: a review and updated meta-analysis","volume":"168","author":"Janunger","year":"2002","journal-title":"Eur J Surg"},{"issue":"4","key":"10.1016\/j.ejso.2006.11.030_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-93-4-533","article-title":"5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer","volume":"93","author":"MacDonald","year":"1980","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ejso.2006.11.030_bib5","first-page":"1800","article-title":"Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH","volume":"21","author":"Nakajima","year":"1994","journal-title":"Gan To Kagaku Ryoho"},{"issue":"Suppl. 3","key":"10.1016\/j.ejso.2006.11.030_bib6","first-page":"S52","article-title":"Adjuvant systemic therapy for women with node-positive breast cancer","volume":"158","author":"The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer","year":"1998","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.ejso.2006.11.030_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.1998.16.1.295","article-title":"Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer","volume":"16","author":"O'Connell","year":"1998","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2006.11.030_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4143\/crt.2004.36.2.103","article-title":"2002 Annual Report of the Korea Central Cancer Registry: based on registered data from 139 hospitals","volume":"36","author":"Shin","year":"2004","journal-title":"Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejso.2006.11.030_bib9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/1097-0142(19820315)49:6<1116::AID-CNCR2820490609>3.0.CO;2-U","article-title":"Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer","volume":"49","author":"The Gastrointestinal Tumor Study Group","year":"1982","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2006.11.030_bib10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.1990.8.8.1362","article-title":"A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer","volume":"8","author":"Coombes","year":"1990","journal-title":"J Clin Oncol"},{"issue":"0","key":"10.1016\/j.ejso.2006.11.030_bib11","first-page":"S25","article-title":"Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives","volume":"54","author":"Sakamoto","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"10.1016\/j.ejso.2006.11.030_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejso.2006.11.030_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ejso.2006.11.030_bib14","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/annonc\/mdf302","article-title":"A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer","volume":"13","author":"Chang","year":"2002","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2006.11.030_bib15","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/1097-0142(19930615)71:12<3813::AID-CNCR2820711205>3.0.CO;2-5","article-title":"A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer","volume":"71","author":"Kim","year":"1993","journal-title":"Cancer"},{"issue":"Suppl. 16","key":"10.1016\/j.ejso.2006.11.030_bib16","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1200\/jco.2005.23.16_suppl.4002","article-title":"Final results of a randomized controlled phase III trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F) to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)","volume":"23","author":"Moiseyenko","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Suppl.\u00a018","key":"10.1016\/j.ejso.2006.11.030_bib17","doi-asserted-by":"crossref","first-page":"LBA4018","DOI":"10.1200\/jco.2006.24.18_suppl.lba4018","article-title":"Randomized phase III trial of\u00a0capecitabine\/cisplatin (XP) vs. continuous infusion of 5-FU\/cisplatin (FP) as first-line therapy in patients (pts) with advanced\u00a0gastric\u00a0cancer (AGC): efficacy and safety results","volume":"24","author":"Kang","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2006.11.030_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(06)70623-4","article-title":"Nodal dissection for patients with gastric cancer: a randomised controlled trial","volume":"7","author":"Wu","year":"2006","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.ejso.2006.11.030_bib19","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1200\/JCO.2005.66.005","volume":"23","author":"Hartgrink","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2006.11.030_bib20","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1200\/JCO.2004.08.026","article-title":"Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial","volume":"22","author":"Hartgrink","year":"2004","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2006.11.030_bib21","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/1097-0142(20010601)91:11<2016::AID-CNCR1227>3.0.CO;2-I","article-title":"Adjuvant 5-fluorouracil plus doxorubicin in D2\u20133 resected gastric carcinoma: 15-year experience at a single institute","volume":"91","author":"Jeung","year":"2001","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2006.11.030_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2168.2000.01358.x","article-title":"Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer","volume":"87","author":"Maehara","year":"2000","journal-title":"Br J Surg"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798306004847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798306004847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T17:00:33Z","timestamp":1587315633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798306004847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0748798306004847"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2006.11.030","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}